The lockdowns ended up contributing to a tough H1FY22 for this business.
However, the thesis is playing out now, with management even starting to give forward guidance.
EBITDA of $32m to $35m is near my normalised target from last year (after adjusting for the recent cash financed acquisition). So my earnings thesis has largely played out.
However, I would expect the market would apply a c.5 to 6x EBITDA multiple to this business. Therefore, there is still SP upside from a multiple re rate.
SP should rise to at least c.65 to 75c before the uptrend is done.
The lockdowns ended up contributing to a tough H1FY22 for this...
Add DUR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.09 |
Change
0.015(1.40%) |
Mkt cap ! $269.4M | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.09 | $1.08 | $215.3K | 198.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4500 | $1.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.09 | 3655 | 9 |
View Market Depth
| Last trade - 14.19pm 06/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.09 |
Change
0.015 ( 1.43 %) |
||||
| Open | High | Low | Volume | ||
| $1.09 | $1.09 | $1.08 | 30218 | ||
| Last updated 14.19pm 06/06/2024 ? | |||||
| DUR (ASX) Chart |